Peripheral Vascular Devices Market: How Minimally Invasive Vascular Care Is Driving Device Innovation

Peripheral vascular diseases are becoming an increasingly important healthcare concern as populations age and the prevalence of diabetes, hypertension, obesity, smoking-related vascular disease, and other cardiovascular risk factors increases.

Peripheral vascular devices play a central role in diagnosing and treating these conditions. Angioplasty balloons, drug-coated balloons, peripheral stents, atherectomy devices, thrombectomy systems, guidewires, catheters, and intravascular imaging technologies are helping physicians perform minimally invasive interventions while reducing the need for more invasive surgical procedures.

The growing preference for endovascular treatment, combined with continued innovation in vascular devices, is reshaping the treatment landscape for peripheral artery disease and other vascular disorders.

The global Peripheral Vascular Devices Market was valued at approximately USD 1,080 million in 2025 and is projected to reach USD 1,955 million by 2035, expanding at a 5.2% CAGR from 2026 to 2035.

Why Is the Peripheral Vascular Devices Market Growing?

The increasing burden of peripheral artery disease (PAD) is one of the primary factors driving demand for peripheral vascular devices.

PAD and other peripheral vascular conditions can restrict blood flow and may lead to serious complications when left untreated. The growing prevalence of diabetes, hypertension, obesity, cardiovascular disease, and age-related vascular disorders is increasing the need for diagnosis and treatment.

The market is also being supported by:

• Increasing prevalence of peripheral artery disease

• Rising incidence of diabetes and cardiovascular disorders

• Growth of the aging population

• Increasing adoption of minimally invasive endovascular procedures

• Greater awareness of vascular disease

• Expansion of vascular intervention centers

• Advances in angioplasty balloons and stents

• Development of atherectomy and thrombectomy systems

• Increasing use of intravascular imaging

These trends are encouraging healthcare providers to adopt technologies that can improve vascular treatment while reducing procedural invasiveness and recovery time.

Angioplasty Balloons Lead the Product Segment

By product type, angioplasty balloons accounted for approximately 19% of the market in 2025, making them the leading product segment.

Angioplasty balloons are widely used to dilate narrowed or obstructed blood vessels during peripheral endovascular procedures.

Their established role in the treatment of peripheral artery disease and vessel stenosis continues to support demand across hospitals, vascular centers, and catheterization laboratories.

Drug-coated balloons are emerging as an important growth area. The BrandEssence report estimates that the drug-coated balloon segment could expand at approximately 8.5% CAGR, supported by their potential to reduce restenosis and improve long-term vessel patency.

Peripheral stents, atherectomy devices, thrombectomy systems, guidewires, catheters, inferior vena cava filters, and hemodynamic flow-altering devices also contribute to the broader product landscape.

Drug-Coated Balloons Are Changing Peripheral Intervention

Drug-coated balloons are becoming increasingly important in peripheral vascular treatment.

These devices combine balloon angioplasty with localized drug delivery and are designed to help reduce the risk of restenosis following vessel treatment.

The growing focus on long-term vessel patency and improved clinical outcomes is supporting adoption of drug-coated technologies.

Drug-eluting stents are also gaining attention as manufacturers continue developing technologies designed to improve vessel outcomes and reduce restenosis.

The continued development of drug-delivery platforms is therefore expected to remain an important area of innovation within the peripheral vascular devices industry.

Peripheral Artery Disease Represents the Largest Application

By application, peripheral artery disease (PAD) accounted for approximately 34% of the market in 2025, making it the largest application segment.

PAD is associated with narrowing or blockage of peripheral arteries and is particularly relevant among older adults and people with conditions such as diabetes and cardiovascular disease.

The treatment landscape includes angioplasty, stenting, atherectomy, thrombectomy, and imaging-guided interventions.

Deep vein thrombosis and other venous diseases are also important areas of demand. According to the BrandEssence report, DVT and venous diseases are among the faster-growing application areas, with an estimated 8% CAGR, supported by increasing awareness, improved diagnosis, and broader treatment options.

Minimally Invasive Endovascular Procedures Are Expanding

The shift toward minimally invasive treatment is one of the most important structural trends in the industry.

Endovascular procedures allow physicians to treat vascular conditions through catheter-based approaches rather than more invasive open surgical procedures.

This can support shorter recovery periods and reduce the physical burden associated with certain vascular interventions.

Hospitals and vascular centers are increasingly adopting angioplasty balloons, stents, atherectomy systems, thrombectomy devices, and intravascular imaging technologies as part of modern endovascular treatment.

The continued expansion of minimally invasive vascular care is expected to create opportunities across both developed and emerging healthcare systems.

Intravascular Imaging Is Improving Procedural Guidance

Intravascular imaging technologies are becoming increasingly relevant to peripheral vascular interventions.

These systems can provide physicians with detailed information about vessel anatomy and lesions during procedures, supporting treatment planning and procedural guidance.

The growing use of image-guided interventions is closely connected to the industry's broader shift toward precision and minimally invasive vascular treatment.

AI-enabled imaging is also emerging as an opportunity, with technologies being developed to support image quality, lesion identification, procedural planning, and treatment guidance.

Conventional Endovascular Devices Continue to Dominate

By technology, conventional endovascular devices accounted for approximately 48% of the market in 2025 according to the report's segment-share table.

These technologies have established clinical applications and remain widely available across healthcare facilities.

At the same time, drug-coated and drug-eluting technologies are developing rapidly. The report identifies drug-coated and drug-eluting technologies as one of the faster-growing technology areas, with an estimated 8.8% CAGR, supported by the focus on clinical outcomes and lower restenosis rates.

Intravascular imaging and mechanical thrombectomy technologies are also expanding the capabilities of peripheral interventions.

Hospitals Remain the Largest End User

Hospitals and healthcare facilities accounted for approximately 43% of the market in 2025, making them the leading end-user category.

Hospitals typically handle high volumes of vascular procedures and have access to specialized professionals, advanced imaging systems, catheterization laboratories, and surgical infrastructure.

The expansion of minimally invasive procedures is also creating opportunities for ambulatory surgical centers and specialty vascular clinics.

According to the BrandEssence analysis, ambulatory surgical centers are expected to grow at approximately 7.8% CAGR, supported by increasing preference for minimally invasive outpatient procedures and efforts to reduce treatment costs.

Outpatient Vascular Care Is Creating New Opportunities

The growing use of outpatient procedures is changing the way selected vascular interventions are delivered.

Ambulatory surgical centers and specialty vascular facilities can provide suitable patients with access to minimally invasive procedures without requiring prolonged hospital stays.

This trend is particularly relevant as healthcare systems seek to improve efficiency and manage rising healthcare costs.

The development of outpatient vascular intervention centers is therefore emerging as an important opportunity for device manufacturers, healthcare providers, and specialized vascular-care networks.

The Aging Population Is Increasing Vascular Disease Burden

Population aging is another important factor influencing the peripheral vascular devices industry.

Older adults are more vulnerable to vascular complications, including PAD, chronic limb-threatening ischemia, and other circulation disorders.

The combination of population aging with rising prevalence of diabetes, obesity, hypertension, and sedentary lifestyles is increasing the long-term burden of vascular disease.

This is encouraging healthcare providers to strengthen early diagnosis, screening, vascular treatment, and long-term disease-management programs.

High Treatment Costs Remain a Challenge

The cost of advanced peripheral vascular procedures remains an important market restraint.

Drug-coated balloons, drug-eluting stents, atherectomy systems, thrombectomy devices, embolic protection technologies, and intravascular imaging platforms can require substantial investment.

Healthcare providers must also account for specialized equipment, trained professionals, procedural expertise, and post-procedure management.

These costs can limit access to advanced vascular interventions, particularly in cost-sensitive and developing healthcare markets.

Regulatory Requirements Can Slow Product Development

Peripheral vascular devices are subject to stringent regulatory and clinical requirements.

Manufacturers need to demonstrate the safety, performance, and long-term effectiveness of new devices through clinical evaluation, quality management, and post-market surveillance.

Requirements related to long-term vessel patency, restenosis, and patient outcomes can increase development timelines and costs.

Regulatory complexity can therefore influence both the pace of product launches and the ability of smaller companies to commercialize innovative technologies.

North America Remains the Largest Regional Market

North America accounted for approximately 42.5% of the global Peripheral Vascular Devices Market in 2025, making it the largest regional market.

The regional market was valued at approximately USD 2,856 million in 2025 and is projected to reach around USD 4,412 million by 2035, expanding at a 3.05% CAGR from 2026 to 2035.

The region benefits from advanced healthcare infrastructure, high prevalence of PAD and cardiovascular disorders, favorable reimbursement frameworks, and strong adoption of minimally invasive vascular interventions.

The presence of major medical device manufacturers and continued technological innovation are also supporting regional development.

The United States Leads North America

The United States accounted for approximately 87% of the North American market in 2025.

The U.S. market was valued at approximately USD 2,487 million in 2025 and is projected to reach USD 3,750 million by 2035, expanding at a 4.20% CAGR.

High healthcare expenditure, advanced vascular-care infrastructure, widespread adoption of endovascular procedures, and strong demand for innovative devices are supporting the U.S. industry.

The report also identifies increasing adoption of drug-coated balloons, thrombectomy, atherectomy, next-generation intervention technologies, and AI-driven imaging as opportunities in the U.S. market.

Europe Maintains a Significant Market Position

Europe accounted for approximately 27.5% of the global market in 2025.

The European Peripheral Vascular Devices Market was valued at approximately USD 1,848 million in 2025 and is projected to reach around USD 2,960 million by 2035, representing a 3.33% CAGR.

The region's established healthcare infrastructure, aging population, high prevalence of cardiovascular and peripheral vascular disease, and increasing use of minimally invasive procedures are supporting demand.

Germany accounted for approximately 20% of the European market in 2025, followed by the United Kingdom at 16%, France at 14%, Italy at 10%, and Spain at 8%.

Asia Pacific Is the Fastest-Growing Region

Asia Pacific accounted for approximately 20% of the global market in 2025 and is projected to expand at a 6.39% CAGR from 2026 to 2035.

The regional market was valued at approximately USD 1,344 million in 2025 and is projected to reach USD 2,680 million by 2035.

Increasing prevalence of diabetes and cardiovascular disease, expanding healthcare infrastructure, rising awareness of vascular disorders, and greater investment in interventional cardiology and vascular surgery are supporting regional growth.

The large patient population and significant number of underdiagnosed or untreated vascular conditions are also creating opportunities for device manufacturers.

China Is Becoming an Important Growth Market

China accounted for approximately 32% of the Asia Pacific market in 2025.

The Chinese Peripheral Vascular Devices Market was valued at approximately USD 430 million in 2025 and is projected to reach USD 938 million by 2035, representing an 8.11% CAGR.

Increasing healthcare infrastructure, a growing burden of cardiovascular disease and diabetes, healthcare reforms, and greater access to advanced medical technologies are supporting the expansion of peripheral vascular interventions in China.

India Offers Expanding Opportunities

India accounted for approximately 14% of the Asia Pacific market in 2025, according to the regional share analysis.

The country's expanding healthcare infrastructure, increasing burden of diabetes and cardiovascular disease, greater awareness of vascular disorders, and growing adoption of minimally invasive interventions are supporting market development.

The expansion of specialized cardiovascular centers and ambulatory vascular-care services can further improve access to peripheral vascular treatment.

AI-enabled vascular imaging and next-generation drug-coated technologies are also identified as emerging opportunities for the Indian market and broader Asia Pacific region.

Latin America and the Middle East & Africa Are Expanding

Latin America represented approximately 6.5% of the global market in 2025 and is projected to expand at a 5.16% CAGR, reaching approximately USD 726 million by 2035.

Brazil represents a major market within the region, supported by its large diabetic population, expanding cardiovascular-care infrastructure, and growing adoption of minimally invasive vascular procedures.

The Middle East and Africa represented approximately 3.5% of the global market in 2025. Saudi Arabia and the United Arab Emirates are investing in advanced healthcare infrastructure and specialized cardiovascular services, while South Africa and other markets are gradually expanding vascular treatment capabilities.

AI Is Emerging in Vascular Imaging and Treatment Planning

Artificial intelligence is becoming an emerging technology opportunity within peripheral vascular care.

AI-enabled platforms can support vascular image analysis, lesion detection, treatment planning, and procedural guidance.

The BrandEssence report highlights the development of software using deep learning algorithms to improve image quality and lesion detection in peripheral vascular procedures.

AI-based technologies may become increasingly relevant as physicians seek more detailed imaging information and greater procedural precision.

Next-Generation Devices Are Expanding Treatment Options

Innovation in peripheral vascular devices is moving toward technologies that can improve long-term vessel outcomes while supporting less invasive procedures.

Key areas of development include:

• Drug-coated balloons

• Drug-eluting peripheral stents

• Bioresorbable vascular scaffolds

• Advanced thrombectomy systems

• Atherectomy technologies

• Intravascular imaging

• AI-assisted vascular imaging

• Image-guided intervention

• Smart vascular implants

The report also highlights ongoing development of polymer and drug-delivery technologies designed to improve long-term patency and reduce restenosis following peripheral vascular procedures.

What Is the Future of the Peripheral Vascular Devices Market?

The global Peripheral Vascular Devices Market is projected to increase from USD 1,080 million in 2025 to USD 1,955 million by 2035.

The industry's next phase will be shaped by continued growth in minimally invasive endovascular treatment, greater use of drug-coated technologies, advances in intravascular imaging, and increasing adoption of AI-supported vascular care.

Several developments are likely to influence the industry:

1. Greater adoption of drug-coated balloons

2. Expansion of drug-eluting peripheral stents

3. Increasing use of intravascular imaging

4. Growth of mechanical thrombectomy technologies

5. Expansion of minimally invasive endovascular procedures

6. Development of AI-assisted vascular imaging

7. Growth of outpatient vascular intervention centers

8. Development of bioresorbable vascular scaffolds

9. Greater focus on personalized vascular treatment

10. Increasing use of digital and remote vascular-care technologies

Conclusion

The Peripheral Vascular Devices Market is evolving as healthcare systems respond to the growing burden of peripheral artery disease and other vascular disorders.

Angioplasty balloons currently represent the leading product segment, while PAD is the largest application. Hospitals and healthcare facilities remain the largest end users, although ambulatory surgical centers are expanding as minimally invasive outpatient procedures become more widely adopted.

North America currently represents the largest regional market, while Asia Pacific is expanding at a faster pace. China and India are becoming increasingly important as healthcare infrastructure improves and access to vascular intervention expands.

At the technology level, drug-coated balloons, drug-eluting stents, intravascular imaging, thrombectomy systems, and AI-assisted vascular technologies are creating new opportunities.

The industry's future will depend on continued innovation in minimally invasive devices, improved vascular imaging, broader access to specialized treatment, and technologies that can improve procedural precision and long-term patient outcomes.

As healthcare providers increasingly prioritize earlier diagnosis, less invasive treatment, and more efficient vascular care, peripheral vascular devices are likely to remain an important part of the evolving cardiovascular intervention landscape.

Explore the Full Peripheral Vascular Devices Market Analysis

For detailed market size, product segmentation, application analysis, technology trends, end-user insights, regional forecasts, country-level analysis, competitive assessment, recent developments, patent and IP trends, and strategic opportunities, explore the Peripheral Vascular Devices Market report from BrandEssence Research.